Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Coates, GB
Anthony Coates, London GB
| Patent application number | Description | Published |
|---|---|---|
| 20090137622 | USE OF PYRROLOQUINOLINE COMPOUNDS TO KILL CLINICALLY LATENT MICROORGANISMS - There is provided the use of compounds of formula I | 05-28-2009 |
| 20100093691 | TOPICAL FORMULATIONS - There is provided topical pharmaceutical compositions comprising compounds of formula I | 04-15-2010 |
| 20100305065 | USE OF 4-(PYRROLIDIN-1-YL)QUINOLINE COMPOUNDS TO KILL CLINICALLY LATENT MICROORGANISMS - There is provided the use of compounds of formula wherein R | 12-02-2010 |
Anthony Robert Milnes Coates, London GB
| Patent application number | Description | Published |
|---|---|---|
| 20090104651 | SCREENING PROCESS FOR ANTIBACTERIAL AGENTS - The present invention relates to a method of preparing a phenotypically antibiotic-resistant subpopulation of stationary phase bacteria by treating stationary phase bacteria with high doses of antibacterial agents, the subpopulation thus identified, a process for identifying new antibacterial agents by testing against the antibiotic-resistant subpopulation, the compounds thus identified and their uses, particularly in treating bacterial infections involving dormant bacteria. | 04-23-2009 |
| 20110052616 | Biological materials and uses thereof - The present invention concerns a peptide molecule or a nucleic acid molecule, for use in medicine and, in particular, for use in preventing or treating a non-cancerous condition or relieving pain in a patient. The invention also relates to a pharmaceutical composition comprising the peptide or nucleic acid molecule of the invention and methods of treatment thereof. | 03-03-2011 |
David Coates, Dorset GB
| Patent application number | Description | Published |
|---|---|---|
| 20090161034 | Drive schemes for driving cholesteric liquid crystal material into the focal conic state - In a cholesteric liquid crystal display device ( | 06-25-2009 |
David Coates, Wimbourne GB
| Patent application number | Description | Published |
|---|---|---|
| 20080198173 | DRIVING OF A CHOLESTERIC LIQUID CRYSTAL DISPLAY APPARATUS - A cholesteric liquid crystal display apparatus is driven in accordance with image data having a predetermined number of possible grey levels. Drive signals are applied to the electrodes of the at least one cell which drive each pixel of the display apparatus into a state selected from a number of predetermined states in accordance with the image data. A number of predetermined states less than the predetermined number of possible grey levels of the image data is used but the image data is error diffusion dithered so that the spatial filtering performed by the eye of the viewer compensates for the low number of states used. By using such a low number of states, there are achieved several advantages in the design of the drive circuit which increase its simplicity and reduce cost. | 08-21-2008 |
| 20090103027 | Cholesteric Liquid Crystal Display Device - A cholesteric liquid crystal display device ( | 04-23-2009 |
| 20090279024 | PROTECTION OF A CHOLESTERIC LIQUID CRYSTAL DISPLAY DEVICE - A cholesteric liquid crystal display device ( | 11-12-2009 |
James Coates, Cambridgeshire GB
| Patent application number | Description | Published |
|---|---|---|
| 20080279732 | Exhaust as Treatment - Apparatus for generating an ammonia-containing gas is described for use in the selective catalytic reduction of NOx contained in the exhaust gases of an IC engine. The apparatus has a hydrolysis reactor ( | 11-13-2008 |
| 20080314027 | Exhaust Gas Treatment | 12-25-2008 |
| 20090120079 | EXHAUST GAS TREATMENT - A thermo-hydrolysis reactor ( | 05-14-2009 |
James Martin Coates, Cambridgeshire GB
| Patent application number | Description | Published |
|---|---|---|
| 20080307967 | Exhaust Gas Treatment - An apparatus for reducing NOx comprising an exhaust conduit ( | 12-18-2008 |
Michael Jonathan Coates, Yorkshire GB
| Patent application number | Description | Published |
|---|---|---|
| 20100311556 | APPARATUS AND METHOD FOR MANUFACTURING METAL CONTAINERS - An apparatus and method for transferring compressed air between machine elements uses a rotary manifold ( | 12-09-2010 |
Nicholas R. Coates, Crowborough GB
| Patent application number | Description | Published |
|---|---|---|
| 20090100578 | Protective Clothing - Protective clothing ( | 04-23-2009 |
Nigel Coates, Essex GB
| Patent application number | Description | Published |
|---|---|---|
| 20090117127 | Novel Compounds and Methods for Their Production - The present invention relates to 11-O-desmethylmacbecin analogues that are useful, e.g. in the treatment of cancer, B-cell malignancies, malaria, fungal infection, diseases of the central nervous system and neurodegenerative diseases, diseases dependent on angiogenesis, autoimmune diseases and/or as a prophylactic pretreatment for cancer. The present invention also provides methods for the production of these compounds and their use in medicine, in particular in the treatment and/or prophylaxis of cancer or B-cell malignancies. | 05-07-2009 |
| 20090209507 | 15-O-Desmethylmacbecin Derivatives and Their Use in the Treatment of Cancer or B-Cell Malignancies - The present invention relates to 15-O-desmethylmacbecin analogues according to the formula (IA) or (IB) herein, or a pharmaceutically acceptable salt thereof: wherein: R | 08-20-2009 |
| 20090253667 | 18 ,21-Didesoxymacbecin Derivatives for the Treatment of Cancer - The present invention relates to 18,21-didesoxymacbecin analogues that are useful, e.g. in the treatment of cancer, B-cell malignancies, malaria, fungal infection, diseases of the central nervous system and neurodegenerative diseases, diseases dependent on angiogenesis, autoimmune diseases and/or as a prophylactic pre-treatment for cancer. The present invention also provides methods for the production of these compounds and their use in medicine, in particular in the treatment and/or prophylaxis of cancer or B-cell malignancies. | 10-08-2009 |
| 20090298804 | Novel Compounds and Methods for Their Production - The present invention relates to 15-desmethoxymacbecin analogues that are useful, e.g. in the treatment of cancer, B-cell malignancies malaria, fungal infection, diseases of the central nervous system and neurodegenerative diseases, diseases dependent on angiogenesis, autoimmune diseases and/or as a prophylactic pretreatment for cancer. The present invention also provides methods for the production of these compounds and their use in medicine, in particular in the treatment and/or prophylaxis of cancer or B-cell malignancies. | 12-03-2009 |
| 20100068203 | 17-Oxymacbecin Derivatives and Their Use in the Treatment of Cancer and/or B-Cell Malignancies - The present invention relates to 17-oxymacbecin analogues that are useful, e.g. in the treatment of cancer, B-cell malignancies, malaria, fungal infection, diseases of the central nervous system and neurodegenerative diseases, diseases dependent on angiogenesis, autoimmune diseases and/or as a prophylactic pretreatment for cancer. The present invention also provides methods for the production of these compounds and their use in medicine, in particular in the treatment and/or prophylaxis of cancer or B-cell malignancies. | 03-18-2010 |
| 20110091452 | 4,5-Dihydromacbecin Derivatives and Their Use in the Treatment of Cancer or B-Cell Malignancies - The present invention relates to 4,5-dihydromacbecin analogues to the formula (IA) or (IB), or a pharmaceutically acceptable salt there of: wherein: R | 04-21-2011 |
| 20110160175 | 18,21-Didesoxymacbecin Derivatives for the Treatment of Cancer - The present invention relates to macbecin analogues that are useful, e.g. in the treatment of cancer, B-cell malignancies, malaria, fungal infection, diseases of the central nervous system and neurodegenerative diseases, diseases dependent on angiogenesis, autoimmune diseases and/or as a prophylactic pre-treatment for cancer. The present invention also provides methods for the production of these compounds involving incorporation of non-natural starter units and their use in medicine, in particular in the treatment and/or prophylaxis of cancer or B-cell malignancies. | 06-30-2011 |
Phil Coates, Leeds GB
| Patent application number | Description | Published |
|---|---|---|
| 20110177136 | METHOD AND PRODUCT - The present invention provides a method of producing a co-crystal, the method comprising the steps of providing a first substance and a second substance, wherein the first and second substances are compatible to form a co-crystal, mixing said first and second substances together, and exposing the mixture of said first and second substances to prolonged and sustained conditions of pressure and shear, sufficient to form a co-crystal of said first and second substance. The prolonged and sustained conditions of pressure and shear are preferably applied in an extrusion process. Associated compositions and uses thereof are also provided. | 07-21-2011 |
Phil Coates, Bradford GB
| Patent application number | Description | Published |
|---|---|---|
| 20090305067 | HEAT-SHRINKABLE FILM - The present invention provides a raulti-layer heat-shrinkable film comprising: a first outer layer comprising a polyester; a second outer layer comprising a polyester; an inner layer comprising a polyolefin; a first intermediate layer between the first outer layer and the inner layer comprising polypropylene grafted with glycidyl methacrylate either directly or through a graft promoter; and a second intermediate layer between the second outer layer and the inner layer comprising polypropylene grafted with glycidyl methacrylate either directly or through a graft promoter. | 12-10-2009 |
Philip D. Coates, Leeds GB
| Patent application number | Description | Published |
|---|---|---|
| 20080287576 | LOW DENSITY ORIENTED POLYMER COMPOSITION WITH INERT INORGANIC FILLER - An oriented polymer composition containing thirty to 95 weight-percent inert inorganic filler and a continuous phase of at least one orientable polymer contains void spaces due to cavitation and has a density of less than 0.8 grams per cubic centimeter, a flexural modulus of 1.4 gigapascals or more, cross section dimensions all greater than 1.5 millimeters, a delamination force value of 44.5 Newtons (ten pounds force) or more and little or no blowing agent. | 11-20-2008 |
| 20100301511 | LOW DENSITY ORIENTED POLYMER COMPOSITION WITH INERT INORGANIC FILLER - An oriented polymer composition containing thirty to 95 weight-percent inert inorganic filler and a continuous phase of at least one orientable polymer contains void spaces due to cavitation and has a density of less than 0.8 grams per cubic centimeter, a flexural modulus of 1.4 gigapascals or more, cross section dimensions all greater than 1.5 millimeters, a delamination force value of 44.5 Newtons (ten pounds force) or more and little or no blowing agent. | 12-02-2010 |
Sam Coates, London GB
| Patent application number | Description | Published |
|---|---|---|
| 20110298824 | SYSTEM AND METHOD OF VIRTUAL INTERACTION - A system for virtual interaction, comprising two or more portable electronic devices, is provided. Each device comprises, in turn, coordinate referencing means operable to define a coordinate system common to the portable electronic devices with respect to a physically defined reference position, position estimation means operable to detect a the physical position of its respective portable electronic device with respect to the reference position, virtual environment generation means operable to generate a virtual environment, and communication means operable to transmit positional data using the common coordinate system from that portable electronic device to another portable electronic device. The virtual environment is shared in common between the portable electronic devices. The virtual environment uses the common co-ordinate system within which each portable electronic device defines a position for itself responsive to its physical position with respect to the reference position. | 12-08-2011 |
Steve Coates, London GB
| Patent application number | Description | Published |
|---|---|---|
| 20110226267 | Transgenic Plants - The invention provides transgenic plants, specifically tobacco plants, which accumulate the amino acid threonine in their leaves. The biosynthetic pathway leading to production of threonine is tightly regulated, and previous attempts to achieve a transgenic plant which overproduces threonine has compromised the fitness of the plants. This invention has overcome these difficulties and found a method of increasing the level of threonine in plant leaves above the corresponding wild type level without compromising plant fitness, comprising altering plant metabolism to achieve increased production of threonine after the initiation of leaf senescence. This invention involves a genetic construct comprising a senescence specific promoter operably linked to a coding sequence encoding a polypeptide having threonine insensitive aspartate kinase activity. | 09-22-2011 |
Timothy William Coates, Winscombe Somerset GB
| Patent application number | Description | Published |
|---|---|---|
| 20120022612 | ELECTROTHERAPY APPARATUS - An apparatus for producing analgesia in a patient through electrical signals applied through electrodes to a patient's body, and methods of treating patients using the apparatus. The apparatus comprises a signal generator arranged to generate a biphasic waveform comprising successive cycles each containing a positive and negative pulse. | 01-26-2012 |
Tom Coates, London GB
| Patent application number | Description | Published |
|---|---|---|
| 20080299989 | CENTRALIZED LOCATION BROKER - A centralized location system includes a location update application programming interface (API) to receive varying types of location inputs for a user from at least one location-providing application. A memory stores a location of the user and the location inputs, wherein the location update API periodically updates in the memory the location inputs when location updates are received from the at least one location-providing application. A location export API, upon request from a location-based service application, processes the location inputs to estimate a location of the user, which location estimate replaces the stored location in memory and is sent to the location-based service application. A user interface enables the user to specify a location granularity for at least one of the at least one location-providing application and the location-based service application. | 12-04-2008 |